Cleared Traditional

K131916 - BPROSOFT CASP PC SOFTWARE

K131916 is an FDA 510(k) clearance for BPROSOFT CASP PC SOFTWARE, manufactured by Healthstats International Pte. , Ltd.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 258-day FDA review.

K131916 · Healthstats International Pte. , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2014
Decision
258d
Days
Class 2
Risk

K131916 is an FDA 510(k) clearance for the BPROSOFT CASP PC SOFTWARE. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Healthstats International Pte. , Ltd. (Eagle, US). The FDA issued a Cleared decision on March 11, 2014 after a review of 258 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Healthstats International Pte. , Ltd. devices

FDA 510(k) Submission Details - K131916

510(k) Number K131916 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 26, 2013
Decision Date March 11, 2014
Days to Decision 258 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
133d slower than avg
Panel avg: 125d · This submission: 258d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 620
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K131916.
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K140121 · Andon Health Co, Ltd. · Jul 2014
DIGITAL AUTOMATIC BLOOD PRESSURE MONITOR BPM20 SERIES
K140583 · Grandway Technology (Shenzhen) Limited · Jun 2014
EV1000 CLINICAL PLATFORM WITH CLEARSIGHT TM FINGER CUFF OR CLEARSIGHT TM SYSTEM
K140312 · Edwards Lifesciences, LLC · Jun 2014
DIGITAL AUTOMATIC WRIST BLOOD PRESSURE MONITOR WBPM22 SERIES
K133618 · Grandway Technology (Shenzhen) Limited · Mar 2014
DIGITAL AUTOMATIC BLOOD PRESSURE MONITOR BPM18 SERIES
K133619 · Grandway Technology (Shenzhen) Limited · Mar 2014
HEM-7320
K133383 · Omron Healthcare, Inc. · Mar 2014